Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: a randomized clinical trial.
- 2024-10-31
- RCT
- Journal of ovarian research 17(1)
- Anahid Shafie
- Ashraf Aleyasin
- Mojtaba Saffari
- Mojtaba Saedi
- Sahar Rostami
- Saeede Rezayi
- Seyed Danial Mohammadi
- Fardin Amidi
- PubMed: 39482765
- DOI: 10.1186/s13048-024-01537-7
- High evidence
- Clinical
No significant differences between AST and placebo groups were observed in OS markers in FF.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 12 mg/day